Please assess the completion status of the following clinical trial:

Trial Title: Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Rheumatoid arthritis~* Eligible for biologic therapy according to BSR/NICE guidelines~Exclusion Criteria:~* Prior biologic therapy~* Contra-indication to anti-TNF therapy or rituximab

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Anti-TNF therapy (Type: ACTIVE_COMPARATOR): Etanercept or adalimumab by s/c injection
- Rituximab therapy (Type: EXPERIMENTAL): Rituximab given by IV infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).